Organoid refers to a three-dimensional mini-organ artificially created in vitro, reproducing the cellular composition, structure, and functional specificity of the organ. We provide a high-tech and high-quality human-derived 3D organoid modeling service, seamlessly combining non animal resources.
Our organoids are created following the highest standard of quality control protocols with standardization of 17 organoid types.
Only €500 per test with results reported within 4 weeks.
Our specialized research team is poised to deliver a tailored model for validating your hypothesis by leveraging advanced methods such as iPSC, CRISPR, Co-culture, cytokine treatments, and much more.
Our organoids are created following the highest standard of quality control protocols with standardization of 17 organoid types.
Only €500 per test with results reported within 4 weeks.
Our specialized research team is poised to deliver a tailored model for validating your hypothesis by leveraging advanced methods such as iPSC, CRISPR, Co-culture, cytokine treatments, and much more.
In Lambda, we can currently create organoids for 20 different organs, utilizing both adult stem cell-derived and iPSC (induced pluripotent stem cell) approaches.
Lambda organoids exhibit high fidelity in mimicking human anatomy, allowing for the depiction of structural, genetic characteristics, and organ-specific functions for each organ.
In Lambda, we can currently create organoids for 11 different organs, utilizing both adult stem cell-derived and iPSC (induced pluripotent stem cell) approaches.
Lambda organoids exhibit high fidelity in mimicking human anatomy, allowing for the depiction of structural, genetic characteristics, and organ-specific functions for each organ.
Preparing
Stomach organoid
Preparing
Liver organoid
Preparing
Pancreatic organoid
Preparing
Hippocampal organoid
Preparing
Spinal cord organoid
Lambda offers 7 modeling services using organoids, providing a range of disease models for studying the mechanisms of diseases and testing the efficacy of drugs.
Lambda offers 7 modeling services using organoids, providing a range of disease models for studying the mechanisms of diseases and testing the efficacy of drugs.
Fibrosis is a disease characterized by repetitive injury and inflammation.
Lambda provides a lung and intestine fibrosis organoid model, enabling drug development and efficacy assessment.
Lambda has developed an organoid model for inflammatory diseases.
We offer inflammation organoid model associated with inflammatory bowel disease and leaky gut syndrome.
A more accurate assessment and monitoring of the efficacy of the microbiome can be achieved with an organoid model closely resembling the human intestine.
Lambda’s hair follicle bearing skin organoid, characterized by high reliability, can be utilized for skin related toxicology and efficacy testing of drugs and cosmetics.
Animal experiments do not fully represent human toxicity assessments.
Lambda’s organoids serve as an excellent alternative.
Lambda boasts consistent high editing efficiency and stability in CRISPR-Cas9 technology.
We specialize in cell reprogramming and gene editing, enabling you to concentrate on your research as we optimize the process, alleviating the burden on your shoulders.
As a virus-infected model, the
utilization of tonsil, adenoid, and lung organoids allows for the evaluation of
antiviral drug efficacy and facilitates virus research.
To gauge the extent of drug absorption relevant to an actual person, organoids are utilized to measure the degree of drug absorption to ensure its usability.
Lambda Biologics GmbH
Deutscher Pl. 5c, 04103 Leipzig, Germany
